Boston Scientific to acquire Apollo Endosurgery for $615 million in cash

Boston Scientific Corp. BSX, +1.18% said Tuesday it has agreed to acquire Apollo Endosurgery Inc. APEN, +65.17% for $10 a share, or about $615 million in cash. The news sent Apollo’s stock, whic...